Although the Covid 19 vaccine rollout has been a great success in the UK, we must continually update our understanding about what is the best way forward.

For some organisations, protecting people from C19 is extremely lucrative.

We need ongoing open conversations between experts with different opinions to help create the optimal road map.

And we must not allow commercial interests to affect the scientific method.